Brief: Personalis Receives Medicare Coverage For Next Personal For Immunotherapy Monitoring Across Late-Stage Solid Tumors
13/05/2026 11:05
May 13 (Reuters) - Personalis Inc PSNL.O: PERSONALIS RECEIVES MEDICARE COVERAGE FOR NEXT PERSONAL® FOR IMMUNOTHERAPY MONITORING ACROSS LATE-STAGE SOLID TUMORS Source text: ID:nBw32PRTBa Further company coverage: PSNL.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Personalis
See all newsBrief: Personalis - Announces Commercial Launch Of Real-Time Variant Tracker In Next Personal Mrd Test
U.S. STOCKS ON THE MOVE-Becton Dickinson, Constellation Energy, Marvell
Personalis slips as BTIG downgrades, sees no rival bid for Tempus deal
Brief: Personalis Receives New Task Order Under U.S. Veterans Affairs Contract For VA MVP
Personalis, Inc. reports results for the quarter ended June 30 - Earnings Summary